Cargando…
Correlation of ABO blood groups with treatment response and efficacy in infants with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide
OBJECTIVE: Not all infants with persistent pulmonary hypertension of the newborn (PPHN) respond to inhaled nitric oxide (iNO) therapy, as it is known to improve oxygenation in only 50% to 60% of cases. In this study, we investigated whether ABO blood groups were a relevant factor affecting the impro...
Autores principales: | Guan, Yi, Jin, Ya, Lu, Yongxue, Ao, Dang, Gu, Pingjiao, Yang, Jiyan, Liu, Guosheng, Han, Shasha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122199/ https://www.ncbi.nlm.nih.gov/pubmed/37087413 http://dx.doi.org/10.1186/s12884-023-05558-w |
Ejemplares similares
-
Clinical response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn.
por: Ko, S. Y., et al.
Publicado: (1998) -
Inhaled nitric oxide in persistent pulmonary hypertension of the
newborn refractory to high-frequency ventilation
por: Al-Alaiyan, Saleh, et al.
Publicado: (1999) -
Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response
por: Nelin, Leif D., et al.
Publicado: (2019) -
ABO Blood Group Is Associated with Response to Inhaled Nitric Oxide in Neonates with Respiratory Failure
por: El-Ferzli, George T., et al.
Publicado: (2012) -
Inhaled iloprost is an effective alternative therapy for persistent pulmonary hypertension in newborns
por: Yıldırım, Şükran
Publicado: (2023)